Health ❯ Diabetes

Treatment Options

Medications Injectable Medications GLP-1 Medications GLP-1 Receptor Agonists Insulin Weight Management Drug Efficacy GLP-1 Agonists Dipeptidyl Peptidase-4 Inhibitors Oral Medications

Deloitte Warns GLP-1 Boom Is Inflating Pharma Returns, Concentrating Risk

Heavy bets on obesity drugs increase vulnerability to shocks.

Canada Approves First Generic Ozempic, Clearing Dr. Reddy’s Semaglutide

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

WHO Backs GLP-1 Weight-Loss Drugs as New Data Highlight Limits and Unknowns

Mexico's Diabetes Crisis Widens as Costs Climb and Vision Risks Mount

Mounjaro Climbs to No. 2 in India by Sales as Wales Maps NHS Path for Weight‑Loss Drugs

Weight-Loss Injections Show Sharp Rebound Eight Weeks After Ending Therapy

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study